Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

HHHFA in COPD Patients, With Chronic Bronchitis

NCT03959982
completed

The Long Term Effects of COVID on Pulmonary Function

NCT05077982
completednot_applicable

Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia

NCT02488031

Clinical Trials (3)

Showing 3 of 3 trials
NCT03959982Not Applicable

HHHFA in COPD Patients, With Chronic Bronchitis

Completed
NCT05077982

The Long Term Effects of COVID on Pulmonary Function

Completed
NCT02488031Not Applicable

Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3